Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 203503
Company: GLENMARK PHARMS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription AB No No
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/02/2015 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/28/2019 SUPPL-3 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.

06/28/2019 SUPPL-2 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

06/28/2019 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

VORICONAZOLE

TABLET;ORAL; 50MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
VFEND VORICONAZOLE 50MG TABLET;ORAL Prescription Yes AB 021266 PF PRISM CV
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 206181 AJANTA PHARMA LTD
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 207049 AKORN
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 206762 APPCO
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 206837 AUROBINDO PHARMA LTD
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 206747 CADILA
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 203503 GLENMARK PHARMS LTD
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 090547 MYLAN PHARMS INC
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 207371 NOVEL LABS INC
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 206654 PRINSTON INC
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 200265 SANDOZ INC
VORICONAZOLE VORICONAZOLE 50MG TABLET;ORAL Prescription No AB 091658 TEVA PHARMS

TABLET;ORAL; 200MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
VFEND VORICONAZOLE 200MG TABLET;ORAL Prescription Yes AB 021266 PF PRISM CV
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 206181 AJANTA PHARMA LTD
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 207049 AKORN
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 206762 APPCO
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 206837 AUROBINDO PHARMA LTD
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 206747 CADILA
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 203503 GLENMARK PHARMS LTD
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 090547 MYLAN PHARMS INC
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 207371 NOVEL LABS INC
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 206654 PRINSTON INC
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 200265 SANDOZ INC
VORICONAZOLE VORICONAZOLE 200MG TABLET;ORAL Prescription No AB 091658 TEVA PHARMS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English